Inventor · disambiguated record
David Klatzmann
Also filed as: KLATZMANN DAVID
34 granted patents·14 pending applications·585 citations·filing 1993–2023
97Inventor score
Top patents by PatentIndex Score
48 records- 0194US10293028B2Use of low dose IL-2 for treating autoimmune related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2017·Granted May 21, 2019·23 cites·20 claims
- 0294US6365405B1Compositions of chondrocytes, preparation and utilizationUNIV PARIS CURIE·Filed 2000·Granted Apr 2, 2002·184 cites·19 claims
- 0392US6872528B2Highly productive packaging linesUNIV PARIS CURIE·Filed 2001·Granted Mar 29, 2005·38 cites·11 claims
- 0490US11306294B2Virus-like particles which can be used in the treatment of autoimmune diseasesUNIV SORBONNE·Filed 2018·Granted Apr 19, 2022·4 cites·13 claims
- 0590US10376564B2Interleukin-2 for treating food allergyUNIV SORBONNE·Filed 2015·Granted Aug 13, 2019·12 cites·19 claims
- 0690US6165470AAlbumin derivatives with therapeutic functionsRHONE POULENC SANTE·Filed 1998·Granted Dec 26, 2000·101 cites·15 claims
- 0789US6485965B1Replicating or semi-replicating viral constructs, preparation and uses for gene deliveryFiled 2000·Granted Nov 26, 2002·44 cites·38 claims
- 0888US9669071B2Method for stimulating T lymphocytes with IL-2KLATZMANN DAVID·Filed 2012·Granted Jun 6, 2017·13 cites·18 claims
- 0987US10765723B2Use of low dose IL-2 for treating autoimmune—related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2019·Granted Sep 8, 2020·5 cites·10 claims
- 1086US9765304B2Synthetic viruses and uses thereofL'UNIVERSITE PIERRE ET MARIE CURIE·Filed 2014·Granted Sep 19, 2017·14 cites·15 claims
- 1184US11559566B2Use of low dose IL-2 for treating autoimmune-related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2020·Granted Jan 24, 2023·1 cites·16 claims
- 1284US8673612B2Synthetic viruses and uses thereofKLATZMANN DAVID·Filed 2001·Granted Mar 18, 2014·18 cites·21 claims
- 1382US11248026B2Compositions and methods for treatment of cytomegalovirusVARIATION BIOTECHNOLOGIES INC·Filed 2017·Granted Feb 15, 2022·2 cites·20 claims
- 1481US6140114ADefective viral vaccine particles obtained in vivo or ex vivoUNIV PARIS CURIE·Filed 1998·Granted Oct 31, 2000·52 cites·24 claims
- 1576US5948675AHost-vector system which can be used in gene therapyUNIV PARIS CURIE·Filed 1995·Granted Sep 7, 1999·33 cites·6 claims
- 1667US12491232B2Low dose IL-2 for treating autoimmune-related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2023·Granted Dec 9, 2025·0 cites·18 claims
- 1767US9757471B2Protozoan variant-specific surface proteins (VSP) as carriers for oral drug deliveryCONSEJO NAC DE INVESTIG CIENTIFICAS Y TECN (CONICET)·Filed 2013·Granted Sep 12, 2017·0 cites·16 claims
- 1862US12428625B2Virus-like particles which can be used in the treatment of allergiesUNIV SORBONNE·Filed 2018·Granted Sep 30, 2025·0 cites·13 claims
- 1961US2024366753A1Viral-like particles for the treatment or prevention of an infection by a coronaviridae virusUNIV SORBONNE·Filed 2022·Application pending·0 cites
- 2060US2005048471A1Albumin derivatives with therapeutic functionsRHONE POULENC SANTE·Filed 2004·Application pending·0 cites
- 2159US11648271B2Genetically modified T lymphocytesKLATZMANN DAVID·Filed 2017·Granted May 16, 2023·0 cites·19 claims
- 2259US2018228913A1Protozoan variant-specific surface proteins (vsp) as carriers for oral drug deliveryCONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN CONICET·Filed 2017·Application pending·0 cites
- 2358US6489142B1Methods and compositions for producing viral particlesAVENTIS PHARMA SA·Filed 1999·Granted Dec 3, 2002·12 cites·26 claims
- 2457US7504483B2α-β C4BP-type recombinant heteromultimeric proteinsUNIV PARIS CURIE·Filed 2006·Granted Mar 17, 2009·0 cites·11 claims
- 2555US2002090364A1Cells designed as traps and their use as medicinesFiled 2002·Application pending·0 cites
- 2654US9457096B2Protozoan variant-specific surface proteins (VSP) as carriers for oral drug deliveryCONSEJO NAC DE INVESTIG CIENTIFICAS Y TECN (CONICET)·Filed 2013·Granted Oct 4, 2016·0 cites·36 claims
- 2754US2024376172A1Interleukin 2 chimeric constructs with targeting specificy to inflamed tissuesILTOO PHARMA·Filed 2022·Application pending·0 cites
- 2853US2003054554A1Albumin derivatives with therapeutic functionsRHONE POULENC SANTE·Filed 2002·Application pending·0 cites
- 2946US11534479B2Use of interleukin 2 for treating Sjögren's syndromeILTOO PHARMA·Filed 2019·Granted Dec 27, 2022·0 cites·14 claims
- 3046US6004803AGenes encoding HSV1-TK containing a deletion of 5' cryptic promoter sites, vectors and cell linesUNIV PARIS CURIE·Filed 1995·Granted Dec 21, 1999·6 cites·17 claims
- 3146US2010233144A1Method for optimizing blood cell transplantsUNIV PARIS CURIE·Filed 2008·Application pending·0 cites
- 3245US12403181B2Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereofILTOO PHARMA·Filed 2019·Granted Sep 2, 2025·0 cites·17 claims
- 3345US5843432ARetroviral vectors for the treatment of tumors, and cell lines containing themUNIV PARIS CURIE·Filed 1993·Granted Dec 1, 1998·9 cites·3 claims
- 3443US5514542AMethods for propagating retrovirus for use in antibody assaysGENETIC SYSTEMS CORP·Filed 1995·Granted May 7, 1996·3 cites·6 claims
- 3543US2010215629A1Treatment of tumors using t lymphocyte preparationsUNIV PARIS CURIE·Filed 2008·Application pending·0 cites
- 3642US2023036793A1Interleukin 2 chimeric constructsILTOO PHARMA·Filed 2020·Application pending·0 cites
- 3741US2003147865A1Cell therapy using immunoregulatory T-cellsFiled 2002·Application pending·0 cites
- 3840US2007128670A1Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and use thereofASSIST PUBL HOPITAUX DE PARIS·Filed 2004·Application pending·0 cites
- 3938US2014236621A1Method for determining a predictive function for discriminating patients according to their disease activity statusCENTRE NAT RECH SCIENT·Filed 2012·Application pending·0 cites
- 4036US9801927B2Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereofKLATZMANN DAVID·Filed 2011·Granted Oct 31, 2017·0 cites·11 claims
- 4136US6333171B1CD4 gene regulatory sequences specifically expressed in mature T cellsUNIV PARIS CURIE·Filed 1996·Granted Dec 25, 2001·4 cites·10 claims
- 4234US7074411B1α-β C4BP-type recombinant heteromultimeric proteinsUNIV REIMS CHAMPAGNE ARDENNES·Filed 1996·Granted Jul 11, 2006·6 cites·24 claims
- 4333US6048525ACells designed as traps and their use as medicinesUNIV PARIS CURIE·Filed 1995·Granted Apr 11, 2000·1 cites·9 claims
- 4432US6383807B1Method of transforming T lymphocytesUNIV PARIS CURIE·Filed 1999·Granted May 7, 2002·0 cites·11 claims
- 4530US2019060407A1Use of interleukin 2 for treating spondyloarthritisHOPITAUX PARIS ASSIST PUBLIQUE·Filed 2016·Application pending·0 cites
- 4630US2002051763A1Host-vector system which can be used in gene therapyFiled 1999·Application pending·0 cites
- 4728US6090378AComposition comprising interleukin-2 and thymidine kinase for the treatment of tumorsPASTEUR INSTITUT·Filed 1997·Granted Jul 18, 2000·0 cites·9 claims
- 4826US8394777B2Treating immunodeficiencies by intrathymic injection of nucleotide sequencesSITBON NAOMI·Filed 2005·Granted Mar 12, 2013·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when David Klatzmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →